How many stocks are there of Stryker?
The current number of stocks of Stryker is 383.7 M undefined.
Stryker Stocks 2024
Stryker Stocks
383.7 M
Ticker
SYK
ISIN
US8636671013
WKN
864952
In 2024, Stryker had 383.7 M outstanding stocks, a 0% change from the 383.7 M stocks in the previous year.
The Stryker Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2028e | 383.7 |
| 2027e | 383.7 |
| 2026e | 383.7 |
| 2025e | 383.7 |
| 2024e | 383.7 |
| 2023 | 383.7 |
| 2022 | 382.2 |
| 2021 | 382.3 |
| 2020 | 380 |
| 2019 | 380 |
| 2018 | 380 |
| 2017 | 380 |
| 2016 | 379 |
| 2015 | 381 |
| 2014 | 383 |
| 2013 | 382 |
| 2012 | 383 |
| 2011 | 390 |
| 2010 | 400 |
| 2009 | 399 |
| 2008 | 414 |
| 2007 | 417 |
| 2006 | 412 |
| 2005 | 411 |
| 2004 | 409 |
Stryker shares outstanding US8636671013 · 864952
The number of shares was Stryker in 2023 — This indicates how many shares 383.7 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Stryker earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Stryker's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Stryker’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Stryker's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 409 M Aktien |
| 2005 | 411 M Aktien |
| 2006 | 412 M Aktien |
| 2007 | 417 M Aktien |
| 2008 | 414 M Aktien |
| 2009 | 399 M Aktien |
| 2010 | 400 M Aktien |
| 2011 | 390 M Aktien |
| 2012 | 383 M Aktien |
| 2013 | 382 M Aktien |
| 2014 | 383 M Aktien |
| 2015 | 381 M Aktien |
| 2016 | 379 M Aktien |
| 2017 | 380 M Aktien |
| 2018 | 380 M Aktien |
| 2019 | 380 M Aktien |
| 2020 | 380 M Aktien |
| 2021 | 382.3 M Aktien |
| 2022 | 382.2 M Aktien |
| 2023 | 383.7 M Aktien |
| 2024e | 383.7 M Aktien |
| 2025e | 383.7 M Aktien |
| 2026e | 383.7 M Aktien |
| 2027e | 383.7 M Aktien |
| 2028e | 383.7 M Aktien |
Stryker Aktienanalyse
What does Stryker do?
Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Stryker's Shares Outstanding
Stryker's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Stryker’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Stryker’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Stryker’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Stryker stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Stryker are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Stryker evolved in recent years?
The number of shares of Stryker has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Stryker as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Stryker?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Stryker pay?
Over the past 12 months, Stryker paid a dividend of 3.05 USD . This corresponds to a dividend yield of about 0.84 %. For the coming 12 months, Stryker is expected to pay a dividend of 3.27 USD.
What is the dividend yield of Stryker?
The current dividend yield of Stryker is 0.84 %.
When does Stryker pay dividends?
Stryker pays a quarterly dividend. This is distributed in the months of January, April, July, October.
How secure is the dividend of Stryker?
Stryker paid dividends every year for the past 34 years.
What is the dividend of Stryker?
For the upcoming 12 months, dividends amounting to 3.27 USD are expected. This corresponds to a dividend yield of 0.9 %.
In which sector is Stryker located?
Stryker is assigned to the 'Health' sector.
Wann musste ich die Aktien von Stryker kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Stryker from 10/31/2024 amounting to 0.8 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.
When did Stryker pay the last dividend?
The last dividend was paid out on 10/31/2024.
What was the dividend of Stryker in the year 2023?
In the year 2023, Stryker distributed 2.835 USD as dividends.
In which currency does Stryker pay out the dividend?
The dividends of Stryker are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Stryker stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Stryker
Our stock analysis for Stryker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stryker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
